SAN DIEGO–(BUSINESS WIRE)– Illumina, Inc. (ILMN) today announced that Caris Life Sciences has selected its MiSeq sequencing system to support Caris evidence-based molecular profiling service. Continue reading
Tag Archives: caris-life
Caris Life Sciences Launches Caris Target Now™ Select for NSCLC, Melanoma, and Cancers of the Breast, Colon, and Ovary
IRVING, Texas, June 26, 2012 /PRNewswire/–Caris Life Sciences, a leading biosciences company focused on enabling precise and personalized healthcare through molecular profiling and blood-based diagnostic services, today announced the launch of Caris Target Now Select, an advanced, evidence-based molecular profiling service for patients with non-small cell lung cancer (NSCLC), melanoma, and cancers of the breast, colon and ovary. Continue reading
Caris Target Now™ Data to be Showcased at ASCO 2012
IRVING, Texas, May 21, 2012 /PRNewswire/ –Caris Life Sciences, a leading biosciences company focused on enabling precise and personalized healthcare through molecular profiling and blood-based diagnostic services, today announced that eight data presentations on Caris Target Now, the foremost evidence-based molecular profiling service, will take place next month at the 2012 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill. One of the most widely used and innovative theranostic (i.e., therapeutic and diagnostic) tools available to oncologists, Caris Target Now is a service that interrogates a patient’s tumor in all phases of the biologic process. Continue reading